(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Characterization of Ngn3-Nkx6.1 and Pdx1-Nkx6.1
transgenic mice. (A) The Ngn3-Nkx6.1 transgenic construct
comprises the Ngn3 promoter fused to Nkx6.1 cDNA followed by
an IRES-eGFP-polyA cassette. (B) In Ngn3-Nkx6.1
embryos at E14.5, 60% of the transgene-expressing;GFP+ cells
express Ngn3 (arrows). (C,D) Whereas 26% of Ngn3+
cells are co-positive for Nkx6.1 in wild-type embryos at E16.5 (C, arrows),
this percentage is increased to 61% in Ngn3-Nkx6.1 embryos (D,
arrows). (E) In the Pdx1-Nkx6.1 transgenic construct, the
Pdx1 promoter drives the expression of Nkx6.1 cDNA and an
IRES-lacZ-polyA cassette. (F-I) lacZ expression in
Pdx1-Nkx6.1 mice is detected in the ventral (vb) and dorsal (db)
pancreatic anlagen at E10.5 (F), in the entire pancreatic epithelium at E14.5
(G), and in a subset of pancreatic cells at E18.5 (H) and postnatal day (P)6
(I). (J-L) ß-galactosidase (ß-gal) and Pdx1 are co-expressed
in pancreata from Pdx1-Nkx6.1 mice at E14.5 (J, ß-gal in green;
K, Pdx1 in red; L, merged). However, some Pdx1+ cells are negative
for the ß-gal reporter (L, arrows). db/vb, dorsal/ventral pancreatic
anlagen. Scale bars: 50 µm in B for B-D and in J for J-L.